PROTARA THERAPEUTICS INC's ticker is TARA and the CUSIP is 74365U107. A total of 30 filers reported holding PROTARA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $714,112 | -30.1% | 427,612 | 0.0% | 0.00% | – |
| Q2 2023 | $1,021,993 | -23.6% | 427,612 | 0.0% | 0.00% | – |
| Q1 2023 | $1,338,426 | +16.8% | 427,612 | 0.0% | 0.00% | – |
| Q4 2022 | $1,146,000 | -9.4% | 427,612 | +0.1% | 0.00% | – |
| Q3 2022 | $1,265,000 | +1.0% | 427,388 | -0.0% | 0.00% | – |
| Q2 2022 | $1,253,000 | -42.6% | 427,404 | 0.0% | 0.00% | – |
| Q1 2022 | $2,184,000 | -25.7% | 427,404 | -1.8% | 0.00% | – |
| Q4 2021 | $2,938,000 | -2.6% | 435,251 | -0.1% | 0.00% | – |
| Q3 2021 | $3,015,000 | -29.2% | 435,813 | -0.3% | 0.00% | – |
| Q2 2021 | $4,258,000 | -40.7% | 437,108 | -4.3% | 0.00% | – |
| Q1 2021 | $7,186,000 | +83.4% | 456,533 | +182.0% | 0.00% | – |
| Q4 2020 | $3,919,000 | +1091.2% | 161,899 | +729.1% | 0.00% | – |
| Q3 2020 | $329,000 | -35.5% | 19,526 | +12.1% | 0.00% | – |
| Q2 2020 | $510,000 | – | 17,423 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Opaleye Management Inc. | 2,558,472 | $43,059,000 | 8.42% |
| CVI Holdings, LLC | 168,836 | $2,842,000 | 1.16% |
| Soleus Capital Management, L.P. | 100,000 | $1,683,000 | 0.89% |
| Ikarian Capital, LLC | 722,443 | $12,158,000 | 0.88% |
| COWEN AND COMPANY, LLC | 124,171 | $2,090,000 | 0.34% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 782,670 | $13,172,000 | 0.32% |
| Cormorant Asset Management, LP | 450,000 | $7,574,000 | 0.29% |
| Rock Springs Capital Management LP | 643,622 | $10,832,000 | 0.28% |
| Perceptive Advisors | 608,544 | $10,242,000 | 0.15% |
| Maven Securities LTD | 100,000 | $1,688,000 | 0.14% |